eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 36
Review paper

The safety of isotretinoin treatment in patients with bone fractures

Bartosz Miziołek, Beata Bergler-Czop, Anna Stańkowska, Ligia Brzezińska-Wcisło

Adv Dermatol Allergol 2019; XXXVI (1): 18-24
Online publish date: 2019/02/22
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Isotretinoin is widely applicable in dermatology, although it may develop severe side effects in the skeletal system. An intention of this review was to establish the safety of oral isotretinoin in patients with bone fractures. Both MEDLINE/Pubmed and SCOPUS databases were searched to investigate the influence of isotretinoin on the skeletal system. The drug shows a strong osteoporotic activity in rats whereas this effect is milder in humans. Biochemical markers of bone turnover remain unchanged except for serum calcium in patients receiving a high dose of isotretinoin. An excessive intake of vitamin A may impair functioning of vitamin D especially in people with a vitamin D deficiency, therefore a similar side effect may also occur in patients on isotretinoin treatment. We suggest reducing the use of isotretinoin after bone injury or continuing the treatment at low dosing with a concomitant correction of vitamin D and calcium status.

isotretinoin, retinoids, bone fracture, bone healing

Dessinioti C, Dreno B. Acne. In: European Handbook of Dermatological Treatments. Katsambas AD, Lotti TM, Dessinioti C, D’Erme AM (eds). Springer-Verlag, Berlin Heidelberg 2015; 3-17.
Bergler-Czop B, Brzezińska-Wcisło L. Pro-inflammatory cytokines in patients with various kinds of acne treated with isotretinoin. Postep Dermatol Alergol 2014; 31: 21-8.
Browne H, Mason G, Tang T. Retinoids and pregnancy: an update. Obstet Gynaecol 2014; 16: 7-11.
Noyes JJ, Levine MA, Belasco JB, Mostoufi-Moab S. Premature epiphyseal closure of the lower extremities contributing to short stature after cis-retinoic acid therapy in medulloblastoma: a case report. Horm Res Paediatr 2016; 85: 69-73.
Ling TC, Parkin G, Islam J, et al. What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH? Br J Dermatol 2001; 144: 630-2.
DiGiovanna JJ, Langman CB, Tschen EH, et al. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. J Am Acad Dermatol 2004; 51: 709-17.
Milstone LM, Insogna KL, Leachman SA. Isotretinoin does have an adverse effect on bone mineral density. J Am Acad Dermatol 2005; 53: 181.
Lind T, Sundqvist A, Hu L, et al. Vitamin a is a negative regulator of osteoblast mineralization. PLoS One 2013; 8: e82388.
Green AC, Poulton IJ, Vrahnas C, et al. RAR-gamma is a negative regulator of osteoclastogenesis. J Steroid Biochem Mol Biol 2015; 150: 46-53.
Ungarelli LF, Hetem CM, Farina Junior JA. Is it safe to operate on patients taking isotretinoin? Aesthetic Plast Surg 2016; 40: 139-48.
Mahadevappa OH, Mysore V, Viswanath V, et al. Surgical outcome in patients taking concomitant or recent intake of oral isotretinoin: a multicentric study-ISO-AIMS study. J Cutan Aesthet Surg 2016; 9: 106-14.
Larson DL, Flugstad NA, O’Connor E, et al. Does systemic isotretinoin inhibit healing in a porcine wound model? Aesthet Surg J 2012; 32: 989-98.
Melhus H, Michaëlsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med 1998; 129: 770-8.
Promislow JH, Goodman-Gruen D, Slymen DJ, Barrett-Connor E. Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study. J Bone Miner Res 2002; 17: 1349-58.
Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among postmenopausal women. JAMA 2002; 287: 47-54.
Michaëlsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med 2003; 348: 287-94.
Barker ME, Blumsohn A. Is vitamin A consumption a risk factor for osteoporotic fracture? Proc Nutr Soc 2003; 62: 845-50.
Kindmark A, Rollman O, Mallmin H, et al. Oral isotretinoin therapy in severe acne induces transient suppression of biochemical markers of bone turnover and calcium homeostasis. Acta Derm Venereol 1998; 78: 266-9.
Margolis DJ, Attie M, Leyden JJ. Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Arch Dermatol 1996; 132: 769-74.
Tekin NS, Ozdolap S, Sarikaya S, Keskin SI. Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acne. Int J Dermatol 2008; 47: 622-5.
Saadi H, Afandi B, Houssami L, et al. Effects of isotretinoin on bone turnover markers and bone mineral density in women with acne vulgaris and vitamin D deficiency: a preliminary study. Int J Diabetes Metabolism 2008; 16: 107-12.
Leachman SA, Insogna KL, Katz L, et al. Bone densities in patients receiving isotretinoin for cystic acne. Arch Dermatol 1999; 135: 961-5.
Garg MK, Kharb S. Dual energy X-ray absorptiometry: pitfalls in measurement and interpretation of bone mineral density. Indian J Endocrinol Metab 2013; 17: 203-10.
Biason TP, Goldberg TB, Kurokawa CS, et al. Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period. BMC Endocr Disord 2015; 15: 15.
Scholes D, Hubbard RA, Ichikawa LE, et al. Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation. J Clin Endocrinol Metab 2011; 96: E1380-7.
Hoover KB, Miller CG, Galante NC, Langman CB. A double-blind, randomized, phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density. Osteoporos Int 2015; 26: 2441-7.
Kocijancic M. 13-cis-retinoic acid and bone density. Int J Dermatol 1995; 34: 733-4.
Erdogan BS, Yüksel D, Aktan S, et al. The effects of isotretinoin treatment on bone mineral density in patients with nodulocystic acne. J Eur Acad Dermatol Venereol 2006; 20: 1006-7.
Nowak B, Matuszewska A, Filipiak J, et al. The negative impact of selective activation of retinoic acid receptors on bone metabolism and bone mechanical properties in rats. Adv Clin Exp Med 2016; 25: 213-8.
Hotchkiss CE, Latendresse J, Ferguson SA. Oral treatment with retinoic acid decreases bone mass in rats. Comp Med 2006; 56: 502-11.
Ertugrul DT, Karadag AS, Tutal E, Akin KO. Therapeutic hotline. Does isotretinoin have effect on vitamin D physiology and bone metabolism in acne patients? Dermatol Ther 2011; 24: 291-5.
Trifirò G, Norbiato G. Type I collagen N-telopeptide variation in adolescents receiving oral isotretinoin for severe acne. J Pediatr Endocrinol Metab 2002; 15: 35-9.
Bergler-Czop B, Miziołek B. Aging – what do we know? Acta Dermatovenerol Croat 2015; 25: 50-6.
Valentic JP, Elias AN, Weinstein GD. Hypercalcemia associated with oral isotretinoin in the treatment of severe acne. JAMA 1983; 250: 1899-900.
Villablanca JG, Khan AA, Avramis VI, Reynolds CP. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid. Am J Pediatr Hematol Oncol 1993; 15: 410-5.
Lemez P. Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day. Eur J Haematol 1995; 55: 275-6.
Cordoba R, Ramirez E, Lei SH, et al. Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid. Eur J Clin Pharmacol 2008; 64: 1031-2.
Hisatake J, Shimozuma J. Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia. Rinsho Ketsueki 2008; 49: 408-12.
Baxi SC, Dailey GE. Hypervitaminosis A. A cause of hypercalcemia. West J Med 1982; 137: 429-31.
Cohen EP, Trivedi C. Hypercalcaemia from non-prescription vitamin A. Nephrol Dial Transplant 2004; 19: 2929.
Bhalla K, Ennis DM, Ennis ED. Hypercalcemia caused by iatrogenic hypervitaminosis A. J Am Diet Assoc 2005; 105: 119-21.
Bergoli RD, Chagas Junior OL, de Souza CE, et al. Isotretinoin effect on alveolar repair after exodontias: a study in rats. Oral Maxillofac Surg 2011; 15: 85-92.
Duncan WE, Guill M, Aton J. Serum calcium concentrations during treatment with isotretinoin. J Am Acad Dermatol 1986; 14: 1096.
Rohde CM, Manatt M, Clagett-Dame M, DeLuca HF. Vitamin A antagonizes the action of vitamin D in rats. J Nutr 1999; 129: 2246-50.
Johansson S, Melhus H. Vitamin A antagonizes calcium response to vitamin D in man. J Bone Miner Res 2001; 16: 1899-905.
Joo NS, Yang SW, Song BC, Yeum KJ. Vitamin A intake, serum vitamin D and bone mineral density: analysis of the Korea National Health and Nutrition Examination Survey (KNHANES, 2008-2011). Nutrients 2015; 7: 1716-27.
Boucher BJ. Serum retinol levels and fracture risk. N Engl J Med 2003; 348: 1927-8.
Chandra RK. Serum retinol levels and fracture risk. N Engl J Med 2003; 348: 1927-8.
Neema S, Mukherjee S, Vasudevan B, et al. Vitamin D deficiency after oral retinoid therapy for ichthyosis. Pediatr Dermatol 2015; 32: e151-5.
Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001; 73: 288-94.
Green AC, Kocovski P, Jovic T, et al. Retinoic acid receptor signalling directly regulates osteoblast and adipocyte differentiation from mesenchymal progenitor cells. Exp Cell Res 2017; 350: 284-97.
Kneissel M, Studer A, Cortesi R, Susa M. Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents. Bone 2005; 36: 202-14.
de Oliveira HT, Bergoli RD, Hirsch WD, et al. Isotretinoin effect on the repair of bone defects – a study in rat calvaria. J Craniomaxillofac Surg 2013; 41: 581-5.
Conaway HH, Persson E, Halén M, et al. Retinoids inhibit differentiation of hematopoietic osteoclast progenitors. FASEB J 2009; 23: 3526-38.
Lind T, Lind PM, Jacobson A, et al. High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in rats. Bone 2011; 48: 496-506.
Novick NL, Lawson W, Schwartz IS. Bilateral nasal bone osteophytosis associated with short-term oral isotretinoin therapy for cystic acne vulgaris. Am J Med 1984; 77: 736-9.
Allen BC, Rhee JS. Complications associated with isotretinoin use after rhinoplasty. Aesthetic Plast Surg 2005; 29: 102-6.
Sharma J, Thiboutot DM, Zaenglein AL. The effects of isotretinoin on wisdom tooth extraction. J Am Acad Dermatol 2012; 67: 794-5.
Berkovitz BK, Maden M, McCaffery P, Barrett AW. The distribution of retinaldehyde dehydrogenase-2 in rat and human orodental tissues. Arch Oral Biol 2001; 46: 1099-104.
Uchibe K, Son J, Larmour C, et al. Genetic and pharmacological inhibition of retinoic acid receptor gamma function promotes endochondral bone formation. J Orthop Res 2017; 35: 1096-105.
Tanaka Y, Nakayamada S, Okada Y. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 325-8.
Crockett JC, Rogers MJ, Coxon FP, et al. Bone remodelling at a glance. J Cell Sci 2011; 124: 991-8.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe